Sphera Funds Management’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Sphera Funds Management’s Portfolio CLCD Stock Details CLCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-358,000	Closed	-$13M	–	136
2016 Q4	$13M	Sell	358,000 -42,000	-11%	-$1.49M	3.3%	8
2016 Q3	$15.3M	Sell	400,000 -100,137	-20%	-$1.48M	2.48%	9
2016 Q2	$4.09M	Buy	500,137 +221,800	+80%	+$1.49M	1.06%	27
2016 Q1	$1.73M	Sell	278,337 -7,188	-3%	-$44.9K	0.37%	61
2015 Q4	$2.39M	Sell	285,525 -31,725	-10%	-$167K	0.35%	71
2015 Q3	$1.23M	Hold	317,250	–	–	0.16%	113
2015 Q2	$2.82M	Buy	+317,250	New	+$2.72M	0.28%	98

Other funds holding CLCD

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Sphera Funds Management's CLCD Position: Q1 2017 in Review

Sphera Funds Management sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 358,000 shares — an estimated $13M sold.

Sphera Funds Management first reported a position in CLCD in Q2 2015 and held it in 7 quarters. The position peaked at $15.3M in Q3 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

Sphera Funds Management reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Sphera Funds Management sold 358,000 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $13M.
Sphera Funds Management first reported a position in CoLucid Pharmaceuticals, Inc. in Q2 2015 and held it in 7 quarters.
Sphera Funds Management's CoLucid Pharmaceuticals, Inc. position peaked at $15.3M in Q3 2016.
1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Sphera Funds Management's 13F filing for Q1 2017, filed 11 May 2017.